Oppenheimer Downgrades Agios Pharma (AGIO) to Perform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Wall St futures rise as AI stocks rally, crude prices fall
- Oil prices slide to 11-day low on hopes of US-Iran diplomacy, Saudi exports
- Warren Buffett transitions to Berkshire’s chairman emeritus
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Qatar Investment Authority targets $20B partnership with JPMorgan - Bloomberg
- Streamflation drives 39% of Americans to cancel streaming in 6 months
Agios Pharma (AGIO) PT Raised to $80 at Credit Suisse; 'Platform opportunities beyond IDH'
February 15, 2018 8:59 AM ESTCredit Suisse raised its price target on Agios Pharma (NASDAQ: AGIO) to $80.00 (from $66.00) while maintaining a Outperform rating.
... MoreAgios Pharma (AGIO) PT Raised to $90 at Leerink Partners
February 15, 2018 7:33 AM ESTLeerink Partners raised its price target on Agios Pharma (NASDAQ: AGIO) to $90.00 (from $85.00) while maintaining a Outperform rating.
... More